(Q55067995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

DNA sequence selectivity of topoisomerases and topoisomerase poisons (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

M Binaschi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

1400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

185-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

The mechanisms of DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

An atypical topoisomerase II from Archaea with implications for meiotic recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

A Model for the Mechanism of Human Topoisomerase I

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Crystal structure of an N-terminal fragment of the DNA gyrase B protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Structure and mechanism of DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Structure and conformational changes of DNA topoisomerase II visualized by electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Biochemical and biophysical analyses of recombinant forms of human topoisomerase I

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

DNA topoisomerase-trapping antitumour drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Resolving the role of topoisomerase II in chromatin structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Nucleosome positioning as a critical determinant for the DNA cleavage sites of mammalian DNA topoisomerase II in reconstituted simian virus 40 chromatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

DNA structural features that lead to strand breakage by eukaryotic type-I topoisomerase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Mechanism of action of DNA topoisomerase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Mapping drug interactions at the covalent topoisomerase II-DNA complex by bisantrene/amsacrine congeners.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Study of allosteric communication between protomers by immunotagging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

DNA sequence specificity of mitoxantrone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Quinolone binding to DNA is mediated by magnesium ions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

Streptonigrin-induced topoisomerase II sites exhibit base preferences in the middle of the enzyme stagger

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900135-3

7 January 2021

10.1016/S0167-4781(98)00135-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748568%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference